Long Term (1 Year) Respiratory Sequelae in Children Surviving an Acute Respiratory Distress Syndrome
Study Details
Study Description
Brief Summary
The purpose of this study is to assess long term (1 year) respiratory sequelae in children surviving an acute respiratory distress syndrome
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The acute respiratory distress syndrome (ARDS) has a high mortality rate in children. Adverse long term sequelae, and in particular respiratory sequelae, have been described mainly in adults. Decrease in diffusing capacity, lung volume and exercise tolerance were observed. Lung function parameters improve during the follow-up until 6 month after discharge from the pediatric intensive care unit (PICU). After that, abnormalities in PFT are observed in a significant proportion of patients. Only two studies described long-term sequelae in children surviving to an ARDS and their results are conflicting. Two studies carried out in adults described the morphologic long-term sequelae by thoracic computed tomography. They showed reticular pattern with a striking anterior distribution in most patients evaluated more than 6 months after discharge from the PICU. There is, to our knowledge, no study describing morphologic pulmonary sequelae by thoracic computed tomography in children surviving to ARDS.
Respiratory assessment: respiratory sequelae in children surviving to the acute respiratory distress syndrome will be evaluated 1 year after discharge from the PICU. Assessment will include a clinical evaluation (respiratory history and physical examination), respiratory function tests and thoracic computed tomography
Study Design
Outcome Measures
Primary Outcome Measures
- Dynamic lung compliance [1 year +- 2 months after discharge from ICU]
Secondary Outcome Measures
- respiratory complaints (cough, wheeze,dypnea at rest on exertion, bronchitis, pneumonia [1 year +- 2 months after discharge from ICU]
- extend of ground glass opacification (CT scan) [1 year +- 2 months after discharge from ICU]
- extend of intense parenchymal opacification [1 year +- 2 months after discharge from ICU]
- extend of reticular pattern [1 year +- 2 months after discharge from ICU]
- extend of decreased attenuation due to emphysema [1 year +- 2 months after discharge from ICU]
- extend of decreased attenuation attributable to small-airway disease [1 year +- 2 months after discharge from ICU]
- carbon monoxide diffusing capacity [1 year +- 2 months after discharge from ICU]
- Pulse oxymetry oxygen saturation at the end of a 6 min walk test [1 year +- 2 months after discharge from ICU]
Eligibility Criteria
Criteria
Inclusion Criteria:
- children surviving to an acute respiratory distress syndrome and alive 1 year after discharge from the PICU
Exclusion Criteria:
-
children suffering from neuromuscular disease
-
children presenting symptoms of chronic respiratory disease before ARDS
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, | Brussels | Belgium | 1020 | |
2 | Hôpital Jeanne de Flandre, Centre Hospitalier Régional et Universitaire de Lille | Lille | France | 59 037 Lille Cedex | |
3 | Hôpital Trousseau, Assistance Publique Hôpitaux de Paris | Paris | France | 75 571 Paris Cedex 12 | |
4 | Hôpital Robert Debré, Assistance Publique Hôpitaux de Paris | Paris | France | 75 935 Cedex 19 | |
5 | Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris | Paris | France | 75743 Paris Cedex 19 |
Sponsors and Collaborators
- University Hospital, Lille
Investigators
- Study Chair: Francis Leclerc, MD, University hospital of Lille , France
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- PHRC 2005/R-1906
- PHRC 2005/R-1906